Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
White light TUR vs PDD-guided TUR in high-risk NMIBC
2013-003898-98Phase 4Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hexaminolevulinate in bladder cancer (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Residual disease at second TUR. Started Oct 2013; status: completed.
02
Drugs
hexaminolevulinate
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2013-003898-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003898-98.